Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine in Esophageal and Gastric Adenocarcinoma
NCT00215462Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2000
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in esophageal adenocarcinoma (EAC), gastric adenocarcinoma, sponsored by Dana-Farber Cancer Institute. Started Jun 2000; status: completed.
02
Drugs
vinorelbine
03
Conditions
esophageal adenocarcinoma (EAC)gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00215462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215462.